Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Hitting positive cashflow

Clever Culture Systems
3:27pm
February 11, 2025
Clever Culture Systems (CC5) has achieved cash flow break-even for operating activities in 2Q25 in line with previous guidance. Further to this, management has guided to the next two quarters being operating cashflow positive. CC5’s strategy is to target large pharmaceutical companies and build on the success so far with AstraZeneca and Bristol Myers. The current installed base is 22 units. Key catalysts include announcements around expansion of additional orders within the customer base and orders from new customers.

Sticker shock offers an opportunity

Car Group
3:27pm
February 10, 2025
CAR 1H25 result was resilient, with pro forma revenue growth of 9-30% across its key markets. However, it was the slight miss vs consensus at EBITDA and the deferral in putting through a price rise in the US business that saw the stock trade lower on the day, in our view. We make minor changes to our FY25-FY27F EBITDA (-1%/-+1%) on the result and guidance update. Our price target increases to A$41.40 on the above changes, an uplift to our longer-term margin assumptions and a DCF valuation roll-forward. Given ~10% TSR upside to our price target, we move to an Add recommendation.

1H beat- looks like a growth stock . . . but it’s not

Ansell
3:27pm
February 10, 2025
1H was better than expected, with strong, double-digit top and bottom line growth, but was mainly supported by acquisition gains, cost outs and one off items. Industrial sales and margins both improved on new product introductions and higher pricing, while Healthcare jumped on normalistion from channel inventory destocking and slowed production. While stocking/restocking appear “neutral” and guidance upgraded c4% at the mid-point, we remain cautious, given Healthcare’s easy gains are now limited, KBU is entering a transition period with risk of sales leakage and customer disruptions, and price increases and cost outs need to offset higher input costs and tariffs. FY25-27 EPS increases 5%, with our DCF/SOTP PT increasing to A$33.38. Hold.

1H25 Earnings: Sales perks

JB Hi-Fi
3:27pm
February 10, 2025
JBH has produced another solid result for the first half, and was ahead of consensus expectations. Sales momentum accelerated in the 2Q driven by demand for tech and consumer electronic products, and has continued into the start of the 2H. Margins were managed better than we expected given the highly promotional and competitive environment, and ongoing cost pressures. We have increased our revenue forecast as a result of strong sales momentum, which has flowed through to 3.5%/4% increase in NPAT in FY25/FY26. We have increased our TP to $92 from $87, but see the current valuation of ~23x FY26 P/E as too expensive, given its 10 year average is ~14x. We retain our HOLD recommendation. With this note, lead coverage of JB Hi-Fi passes to Emily Porter.

Strategic review is key

MedAdvisor
3:27pm
February 10, 2025
Last November, MDR announced a strategic review to help restore value to the business which has seen the market capitalisation fall over 65% since June 2024. The outcome of the review is expected to be announced in 3Q25. The 2Q25 cashflow reported lower revenue and margins than the previous corresponding period. Reflecting the lower than expected US flu vaccination rates. Management has guided to a positive EBITDA for FY25 (consensus A$2.0m). The consensus mean target price is A$0.25.

Still undercooked but getting there

Domino's Pizza
3:27pm
February 7, 2025
DMP’s now regular pre-reporting trading update was better than feared with underlying PBT in line with consensus and no major change/reset of the business announced which was widely expected. New management have so far identified A$34.1m of annualised EBIT savings for the DMP network with more to come. Given the review of the cost base is continuing, DMP has yet to determine both the size of the total savings pool and how it plans to balance how much of the savings will flow to its franchise network (to lift unit economics) vs its own bottom line. Management indicated on the conference call that in the near-term, a greater weighting of savings would likely be reinvested in the network to lift unit economics and reignite organic growth. DMP is making positive steps in the right direction, in our view. However, the key for us to turn positive is a clearer picture on what future organic top line growth will look like going forward. HOLD maintained. As part of the trading update, DMP announced A$34.1m of annualised savings with more to come. Part of these savings (A$15.5m EBIT) is the closure of 205 loss-making stores occurring in the 4Q25. 172 (58 Franchise and 114 Corporate) of those store closures will be in Japan. DMP will incur a one-off impact of A$97.2m in FY25 for these closures (A$37.4m cash impact). Management said in the call that it believes the store network has now been right-sized for future growth and doesn’t expect any future store closures. DMP has also identified A$18.6m of annualised savings associated with simplifying the network and the cost base and identifying opportunities to buy better and spend better in areas including food, packaging, and technology. Given the review of the cost base is continuing, DMP has yet to determine both the size of the total savings pool and how it plans to balance how much of the savings will flow to its franchise network (to lift unit economics) vs its own bottom line. At the FY24 result, on our estimates, DMP needed to lift average sales per store (referring to its franchise partner dashboard reported at FY24) by ~10% to achieve the desired 3 year payback. This would’ve taken ~3 years to achieve. We think the right move is for any cost savings to be reinvested in the franchise network so that the 3 year payback period is achieved sooner rather than later. DMP plans to provide a more detail update on its turnaround strategy at an Investor Day in 2H25.

Expanding its pool of Brown Label ATM customers

Findi
3:27pm
February 7, 2025
FND has announced a new Brown Label ATM (BLA) agreement with Union Bank of India (UBI). The contract is for 7+ years and will deliver A$75m-A$80m of total revenue and A$33m-A$38m of EBITDA over the contract life. The deal is obviously a positive, in our view, noting it both diversifies FND’s BLA customer base, whilst also being strongly value accretive. We upgrade our FND FY25F/FY26F/FY27F EPS by >10% (off low bases) on both incorporation of the UBI deal into our numbers, and some tweaking of our broader earnings forecasts. Our PT is set at A$7.68 (previously A$7.17). FND management appear to be executing well on the company’s overall build out, and with +50% upside to our blended valuation (A$7.68) we maintain our ADD call.

Cessation of coverage

Percheron Therapeutics
3:27pm
February 7, 2025
PER recently released its 2Q report showing a closing cash balance of A$17.4m as at the end of December. Key new information in the report was an estimated trial closure cost estimate of between A$6-7m in line with our expectations. Costs for trial closure and ongoing administrative operating cost burn will be partially offset by R&D rebates. Considering PER’s cash balance and the expected inbound/outbound cash costs ahead, our prior expectations of A$10m of cash balance remaining looks about right on a 12-month forward view, which equates to ~1 cps in value. As highlighted in our topline result note, we held limited hope of PER’s post-hoc analyses bearing significant sub-group clinical utility given the presented topline results other than providing context. The updated data presented subsequently has reconfirmed this, with the drug having the expected pharmacological response however failing to show any meaningful effect on the outcome measures. Potential hypotheses range from the dose being too low, alternative disease mechanisms overpowered the benefit of suppressing CDd+ lymphocytes, to the endpoints being too insensitive to detect a treatment effect. In any case, PER has effectively ‘closed the book’ on avicursen development. The result is a company shell with limited asset value outside of cash backing minus expected outflows. As with most listed shells, we would expect a new asset to be brought forward in time to utilize the residual value of the corporate entity and cash balance however highlight the value outside of cash backing post contractual obligations should be made on a case-by-case basis if and when a new direction surfaces. Given the limited information and unknowns with a likely change of direction, we discontinue coverage of Percheron Therapeutics (PER AU). Our forecasts, target price and recommendation should no longer be relied upon for investment decisions.

Hard to fault

REA Group
3:27pm
February 6, 2025
REA’s 1H25 result was a small beat versus consensus across most key metrics. Operationally, the group reported strong revenue growth in its major business segments, i.e Australia Residential, (+21% on pcp) and REA India (+46% on pcp). REA reiterated its expectations for double-digit yield growth for FY25, and noted that whilst volumes were resilient in the first half, the 2H has the business cycling some strong listings volume in the pcp. In what was arguably a surprise, CEO Owen Wilson announced his intention to retire. Group EBITDA estimates across FY25-FY27 remain largely unchanged (-~0.5-1%). Our DCF-derived price target rises to A$2 (from A$215) with the above changes offset by a valuation roll-forward. However, at ~29x FY26F EV/EBITDA, REA is trading 1 standard deviation rich versus its 10 year average. Hold maintained.

Market confidence still swinging wildly

Beach Energy
3:27pm
February 6, 2025
BPT has been on an interesting ride, it gives the impression of the street regularly finding new reasons to be bullish on the stock ahead of the next downgrade. This seemed at play once again with BPT rallying hard post its December Perth Basin site visit ahead of a somewhat disappointing 1H25 update. A largely in line 1H25 result, with a dividend miss, continued troubles at Waitsia, narrowed FY25 guidance that could trigger consensus downgrades, and capex skew that puts pressure on 2H FCF generation. Post the recent rally and entering a tougher 2H with still some important questions to answer, we pullback our recommendation to Hold (from Add).

News & Insights

From Houthi attacks on Suez Canal shipping to Trump’s Operation Rough Rider and Iran’s nuclear facility strikes, explore how these events shape oil prices.

At the beginning of the week, I was asked to write something about Iran. When I started looking at what had been happening , I realised that what we were talking about begins with an action by a proxy of Iran back in November 2023. How  that was initially handled with the Biden regime, and how then it was dealt with  deftly by Trump this year,   in turn led to  the need for an attack on Iran's nuclear facility.

Winston Churchill noted in his first volume of his history of the Second World War that it was important to understand that the United States is primarily a naval power. Indeed, the US remains the world dominant naval power. As such, two major strategic concerns remain for the US : the control of the Suez Canal and the Panama Canal .

To the US The idea that another country might block access to either of these must be intolerable. Yet what began happening, beginning on the 19th November 2023, was that , Houthi rebels that controlled a the northern part of a small country in southwestern Arabia, began to act. These Houthi rebels were acting as a proxy for Iran. They were funded by Iran, and armed with Ship-killing rockets, by Iran.

By February 2024, they had attacked 40 ships which had been attempting to sail northwards towards the Suez Canal. By March 2024, 200 ships had been diverted away from the Suez Canal and forced to make the longer and more expensive voyage around the Cape of Good Hope of South Africa. At this point, I think The Economist magazine said that this was the most severe Suez crisis since the 1950s.

The U.S. did respond. On the 18th December 2023, the U.S. had announced an international maritime force to break the Houthi blockade. On the 10th January, the UN National Security Council adopted a resolution demanding a cessation of Houthi attacks on merchant vessels.

As of the 2nd January 2024, the Houthis had already recorded 931 American and British airstrikes against sites in Yemen. Then Trump came to power. To Trump, the idea of the proxy of Iran blockading the Suez Canal could not be tolerated.

From the 15th March 2025, Trump began "Operatation  Rough Rider". This was named for the cavalry commanded by the then-future President Theodore Roosevelt, who charged up San Juan Hill in Cuba during the Spanish-American War of 1898. The U.S. then hit the Houthis with over a thousand airstrikes. So they were bombing at ten times the rate they previously had been. The result of that was that by the 6th March 2025, Trump announced that the Houthis, these proxies of Iran, had capitulated as part of a ceasefire brokered by Oman. This directly led to the main game.

It was obvious that the decision to do the unthinkable, and block the Suez Canal, had come from Iran.
What other unthinkable things was Iran considering?

It is obvious that Trump now believed that the next unthinkable thing that Iran was considering was nuclear weapons. As Iran's other proxies collapsed, Iran's air defence collapsed. In turn, this gave Trump the room to act, and he took it. He launched a bombing raid which severely disabled Iran's nuclear capacity. Some say it completely destroyed it.

Iran retaliated by launching 14 rockets at the American base in Qatar, warning the Americans this was going to happen, and this had no other effect than allowing Iran to announce a glorious victory by themselves over the Americans. Iran had thought the unthinkable and had achieved what was, to them, as a result, an unthinkable reverse.

The ceasefire that has followed has been interpreted by markets as a relief from major risk. Now, the major effect of this on markets has been a dramatic rocketing in the oil price, followed by a fall in the oil price. So I thought I’d look at the fundamentals of the oil price, from running two of my models of the Brent price, using current fundamentals.

Now, the simplest model that I’ve got explains 63% of monthly variation of the Brent oil price. And it’s based on two things. One is the level of stocks in the U.S., which are published every week by the Energy Information Administration .  Those stocks are  down a bit in the most recent months because this is the summer driving season where oil stocks are being drawn down to provide higher demand for gasoline. So that’s a positive thing. And the other thing that I’ve been talking about this year is that I think  we’re going to see a steady fall in the U.S. dollar, and that’s going to generate the beginning of a recovery in commodities prices. So if I also put the U.S. dollar index into this model, it gives me an equilibrium model now of $78.96. And that’s about $US12  higher than the oil price was this morning.

If I strengthen that model by adding the U.S. CPI, because, you know, the cost of production cost of oil raises over time, that increases the power of the model . And that lifts the equilibrium price very considerably to $97 a barrel, which is $30 a barrel higher than it currently is. So I regard that as my medium-term model, and the first one is my short-term model.

What’s really interesting is that the U.S. dollar  has continued to fall.  That puts further upward pressure  on the oil price. So in spite of this crisis having been solved, I think we’re going to see more upward price action on the oil price by the end of the year.

Read more
The US economy is growing strongly at 2.34% in Q2 2025 but is expected to slow to 1.4% in 2025, with falling interest rates and a weaker US dollar likely to boost commodity prices, benefiting Australian markets. Michael Knox discusses.

We think the US economy is currently experiencing solid growth, with data from the Chicago Fed  National Activity Index indicating an annual growth rate of just above  2%. This aligns with projections from other parts of the Federal Reserve System, such as the New York Fed. The New York Fed’s weekly Nowcast, updated every Friday, estimates that for the second quarter of 2025, the US economy is growing at an annualised rate of 2.34%, surpassing the 2% mark. This robust growth is consistent with our model’s view that the US economy is now performing strongly. However, we anticipate a slowdown in the second half of 2025.

On 18 June the Fed released its Summary of Economic Projections  with the Federal Reserve’s  forecasting US GDP growth to drop to 1.4% in 2025, down from their March estimate of 1.7%. Looking further ahead, growth is expected to pick up slightly to 1.6% in 2026 and 1.8% in 2027, aligning with the long-term trend growth rate of around 1.8%. We believe this recovery trend could be even  higher,  driven by reduced regulation under the second Trump administration and aggressive tax write-offs for companies building factories in the US, allowing 100% write-offs for equipment and buildings in the first year. This policy should foster stronger systemic growth.

Economic Projections of the Federal Reserve

The Fed expects that as the economy slows,  unemployment is projected to rise to 4.5% from the current level of 4.2%. Inflation, measured by the Consumer Price Index (CPI), is running at 3.5% this year, approximately 50 basis points higher than the Personal Consumption Expenditures (PCE) index of 3.0%, with 1.6% of this  inflation  attributed to tariffs. The Fed expects PCE Inflation  to ease to 2.4% in 2026 and 2.1% in 2027. The Federal Reserve anticipates cutting the effective  federal funds rate, currently at 433 basis points (according to the New York Fed), by 50 basis points by the end of 2025, followed by an additional 25 basis points in each of the next two years. This aligns with our own Fed Funds rate  model’s current equilibrium federal funds rate of  3.85% . The Fed Outlook  supports our scenario of a slowing US economy and rate cuts in the second half of 2025 and beyond. A falling US dollar is then expected to exert upward pressure on commodity prices, benefiting Australian Equity markets.

Taking questions during the Press Conference after releasing the Fed statement  ,Federal Reserve Chair Jay Powell,   addressed the certainty and uncertainty surrounding the inflationary effects of tariffs. Initially, at the start of 2025, the inflationary impact of tariff policies was unclear, but three months of favourable inflation data have provided this clarity, indicating that the inflationary effects are less severe than anticipated. Powell noted that the Feds own uncertainty on the inflationary effects of  tariffs  peaked in April 2025, and the Federal Reserve now has a clearer understanding that  the inflation effects, are lower than initially expected.

The Fed view  supports our own scenario of a slowing US economy in the second half of 2025, allowing for Fed rate cuts  . This in turn should then lead to  a falling US dollar, which we in turn  expect to drive rising commodity prices.

Read more
The Your Wealth publication is our half yearly scrutiny into current affairs for wealth management. Our latest Issue 29 is out now.

The second half of 2025 will be an interesting time for everyone. Geopolitical uncertainty prevails. How will all of this impact the Australian investor and in particular, their wealth and retirement savings? Whether you are an accumulator, saving for short- and long-term goals, or a retiree, hoping for a comfortable retirement, the ability to manage this uncertainty will be key.

When we published the previous Your Wealth – First Half 2025, the Division 296 Bill (Div296) was also facing uncertainty. The Bill was eventually blocked in the Senate prior to the Federal Election. The Labor Party succeeded in winning so it’s Ground Hog Day for Div296. The Government doesn’t have the numbers in the Senate to pass the Bill without support from other parties. The Greens are the likely negotiating party but will undoubtably have their own agenda. Regardless, there is a high probability this legislation will be passed once Parliament resumes.

Our message to our clients is to wait until we know more details and to not act in haste.

In addition to our Feature Article which provides further insights on Div296, this edition also Spotlights the Aged Care changes due this year, with the start date pushed back to 1 November.

We hope readers enjoy this edition of Your Wealth.


Morgans clients receive exclusive insights such as access to our latest Your Wealth publication. Contact us today to begin your journey with Morgans.

      
Contact us
      
Read more